Vale Sandra L, Said Maria, Smith Jill, Joshi Preeti, Loh Richard Ks
National Allergy Strategy, Sydney NSW 2000, Australia.
Australasian Society of Clinical Immunology and Allergy (ASCIA), Sydney NSW 2000, Australia.
World Allergy Organ J. 2022 Oct 13;15(11):100706. doi: 10.1016/j.waojou.2022.100706. eCollection 2022 Nov.
Allergic diseases have become an increasing health issue worldwide, being one of the fastest growing chronic diseases in Australia and other westernized countries. In 2013, allergic diseases were reported to affect 20% of the Australian population. Despite the high prevalence there was no national strategy to address these complex health issues, to enable the health system to manage the increasing number of patients. This project aimed to develop and implement a national strategy to improve allergy management in Australia, with a view of improving the quality of life of people living with or caring for someone with allergic diseases.
The need for a national strategy to improve allergy management was identified. The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA) worked together as partners to progress a national strategy using a theoretical model to underpin its development. Unrestricted education grants were sought to fund engagement with stakeholder organizations for both development and implementation summits. Several stages of advocacy were undertaken.
The National Allergy Strategy was developed as a partnership between ASCIA and A&AA. The Kotter's Change Management Model provided the basis for the steps undertaken to develop and implement the National Allergy Strategy. Two Allergy Summits, one for development and the other for implementation, were held. Several events were held to advocate for federal government funding. Five individual funding grants were achieved to implement National Allergy Strategy projects addressing the most urgent issues.
The development of the National Allergy Strategy, a partnership between ASCIA and A&AA, was important in enabling successful advocacy for funding and implementation of important Australia-wide projects. The partnership has also helped facilitate engagement with key stakeholders to help advocate for funding and provide guidance and expertise in project implementation and resource development. The National Allergy Strategy has been successful in attracting funding to implement projects and develop resources urgently needed. The National Allergy Strategy has also provided a framework and a collaborative approach, for advocacy for further funding and future work to be undertaken.
过敏性疾病已成为全球日益严重的健康问题，是澳大利亚和其他西方国家中增长最快的慢性病之一。2013年，据报道过敏性疾病影响了20%的澳大利亚人口。尽管患病率很高，但却没有国家战略来应对这些复杂的健康问题，以使卫生系统能够管理日益增多的患者。该项目旨在制定并实施一项国家战略，以改善澳大利亚的过敏症管理，从而提高患有过敏性疾病或照顾此类患者的人们的生活质量。
确定了制定国家战略以改善过敏症管理的必要性。澳大利亚临床免疫与过敏学会（ASCIA）和澳大利亚过敏与过敏反应协会（A&AA）作为合作伙伴共同努力，采用一种理论模型为其发展提供支撑，推进一项国家战略。寻求无限制教育资助，以为与利益相关组织在制定和实施峰会方面的合作提供资金。开展了几个阶段的宣传活动。
国家过敏症战略是ASCIA和A&AA合作制定的。科特变革管理模型为制定和实施国家过敏症战略所采取的步骤提供了基础。举办了两次过敏症峰会，一次用于制定，另一次用于实施。举办了几次活动以争取联邦政府的资金。获得了五项个人资助，用于实施国家过敏症战略项目，以解决最紧迫的问题。
由ASCIA和A&AA合作制定的国家过敏症战略，对于成功争取资金支持以及实施重要的全澳项目至关重要。这种合作关系还有助于促进与关键利益相关者的互动，以争取资金支持，并在项目实施和资源开发方面提供指导和专业知识。国家过敏症战略成功吸引了资金来实施项目并开发急需的资源。国家过敏症战略还提供了一个框架和一种合作方法，用于争取更多资金以及开展未来工作。
